Medicine page 11
Pro-Bowl Player's Suicide Renews Head Trauma Debate
Ibuprofen could reduce altitude sickness
Fort Belvoir buys BSD-500 Hyperthermia system
CMS Plans Pilot Program for Mental Health
Lab21 launches Clinical Genomics Center in US
Unilife in targeted organ delivery device supply agreement
Sluggish uptake of new medication management programs
Millennium Dental, IALD sign renewal agreement with Seattle Study Club
Sectra to distribute PenRad mammography information system
Pharmacists need to be “medicineswise” when recommending generic substitution to consumers, the NPS warns.
As reported by Pharmacy News, Ranbaxy’s Trovas, the first generic atorvastatin, will be available in Australian pharmacies by the end of this week, but the NPS has said switching brands might not be an option for everyone.
The warning comes as the Generic Medicines Industry Association (GMiA) urged pharmacists against bulk purchases of generic medicines in advance of market competition, in a press release.
“With any medicine, making the decision to change brands can have both benefits and risks,” the NPS said.
“For some people – such as those with allergies to gluten or lactose which may be added as fillers in tablet manufacturing – switching brands...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.
About this site |